Evaluation of a smartphone app to maintain skin protection behaviour in patients with work-related hand eczema as part of a maintenance programme: protocol for the quasi-randomised controlled trial 'TecNaP-RCT'

评估一款智能手机应用程序在维持职业性手部湿疹患者皮肤保护行为方面的效果,作为维持治疗方案的一部分:准随机对照试验“TecNaP-RCT”方案

阅读:2

Abstract

BACKGROUND: Work-related hand eczema (WRHE) is a common occupational disease in Europe, associated with impaired quality of life and a substantial socioeconomic burden. As skin protection behaviour critically influences disease course, mobile health interventions may help establish and maintain routines. The smartphone app 'Mein Hautschutz im Alltag' (MiA; German for 'My Skin Protection in Everyday Life') was developed to support patients with WRHE, but its clinical effectiveness has not yet been evaluated. METHODS: This quasi-randomised controlled trial will enrol 286 adults with WRHE attending a 3-week inpatient programme at a specialised dermatology clinic. Participants are allocated in clusters based on admission date to either care as usual (control) or care as usual plus an individual goal-setting interview and a 6-month access to the MiA app (intervention). The primary outcome is change in skin protection behaviour from baseline to 6 months post-discharge. Secondary outcomes include clinical and self-rated skin condition, action control, and quality of life. Analyses will follow the intention-to-treat principle using linear mixed models. DISCUSSION: This is the first systematic evaluation of the MiA app's effectiveness in patients with WRHE in a quasi-randomised controlled trial. By combining a structured goal-setting interview with the MiA app, the intervention aims to support the long-term adoption and maintenance of protective behaviours in both occupational and private settings. Key limitations include the quasi-random allocation by admission date (no true randomisation), lack of allocation concealment and blinding, reliance on self-reported primary outcomes, and a 6-month follow-up. Despite these constraints, the pragmatic design aims to generate decision-relevant, real-world evidence for WRHE care. TRIAL REGISTRATION: German Clinical Trial Registry DRKS00036627. Registered on April 14, 2025.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。